A SINGLE CENTER, 5-PART STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF GAL-101 SALT IN HEALTHY ADULT AND ELDERLY PARTICIPANTS
Clinical trial NCT07780604 · COMPLETED
Trial details
- NCT number
- NCT07780604
- Sponsor
- Galimedix Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-18
- Primary completion
- 2025-09-18
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.